Leczenie przewlekłego wirusowego zapalenia wątroby typu C u pacjenta leczonego dializą otrzewnową z powodu przewlekłej choroby nerek oraz u pacjenta po transplantacji nerki — opisy przypadków

Abstract

Introduction of non-interferon therapy has become a milestone in viral C hepatitis treatment and allowed to reach a sustained viral response in over 90% of patients treated this way. Dialysed patients and patients after solid organ transplantation are espe­cially exposed to HCV infection. The case studies of patients presented in the article show that despite the higher risk of side effects and possible interac­tions — with immunosuppressive drugs especially — thanks to perfect cooperation between Outdoor Departments of Infectious Diseases and Nephrology, effective and safe therapy is possible even in this special group of patients.